Abstract
COVID-19 has been declared as a global pandemic by the World Health Organization (WHO) on March 11, 2020. In this paper, we investigate various aspects of the clinical recovery of the first 1000 COVID-19 patients in Singapore, spanning from January 23 to April 01, 2020. This data consists of 245 clinically recovered patients. The first part of the paper studies the descriptive statistics and the influence of demographic parameters, namely age and gender, in the clinical recovery-period of COVID-19 patients. The second part of the paper is on identifying the distribution of the length of the in-hospital stay (LOS) for the patients. Based on the hospital protocols followed in Singapore, this is equivalent to the virus shedding period. We determine a periodization based on critical changes in the transmission model. As expected, the overall recovery rate has reduced drastically during the exponential increase of incidences. However, our work on identifying parameters for a regression model shows that there is a shift in the age-group of incidences to the younger population, and the recovery-period of the younger population is considerably lower. Here, we have estimated the most likely length of in-hospital stay to be 9 days, as opposed to 15 or 20 days. Overall, the prognosis of COVID-19 indicates a reduction in length of in-hospital stay owing to the government-mandated practices of restricted mobility of the older population and aggressive contact tracing.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The authors have not received any external funding for conducting this work.
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All the data used for this work has been obtained from the press releases on the official website of the Ministry of Health, the Government of Singapore.
